ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 92 filers reported holding ARATANA THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $933,000 | -23.9% | 129,892 | -0.8% | 0.00% | -50.0% |
| Q3 2016 | $1,226,000 | +55.2% | 130,943 | +4.7% | 0.00% | +100.0% |
| Q2 2016 | $790,000 | +32.6% | 125,058 | +15.9% | 0.00% | 0.0% |
| Q1 2016 | $596,000 | +0.7% | 107,901 | +1.7% | 0.00% | 0.0% |
| Q4 2015 | $592,000 | -33.3% | 106,058 | +1.0% | 0.00% | 0.0% |
| Q3 2015 | $888,000 | -45.0% | 104,997 | -1.8% | 0.00% | -50.0% |
| Q2 2015 | $1,616,000 | +20.9% | 106,880 | +28.0% | 0.00% | 0.0% |
| Q1 2015 | $1,337,000 | -8.7% | 83,491 | +1.5% | 0.00% | 0.0% |
| Q4 2014 | $1,465,000 | +78.2% | 82,225 | +0.4% | 0.00% | +100.0% |
| Q3 2014 | $822,000 | -24.5% | 81,899 | +17.4% | 0.00% | 0.0% |
| Q2 2014 | $1,089,000 | +157.4% | 69,782 | +206.0% | 0.00% | 0.0% |
| Q1 2014 | $423,000 | +17.5% | 22,803 | +21.0% | 0.00% | 0.0% |
| Q4 2013 | $360,000 | +50.0% | 18,851 | +28.1% | 0.00% | – |
| Q3 2013 | $240,000 | – | 14,714 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Engaged Capital LLC | 3,487,149 | $21,376,000 | 3.96% |
| Broadfin Capital, LLC | 4,083,135 | $25,030,000 | 3.29% |
| MPM ASSET MANAGEMENT LLC | 250,000 | $1,533,000 | 1.30% |
| GENERAL AMERICAN INVESTORS CO INC | 1,599,365 | $9,804,000 | 1.03% |
| Grandeur Peak Global Advisors, LLC | 821,038 | $5,033,000 | 0.65% |
| CADENCE CAPITAL MANAGEMENT LLC | 307,294 | $1,884,000 | 0.19% |
| Redmond Asset Management, LLC | 60,176 | $369,000 | 0.18% |
| Alambic Investment Management, L.P. | 65,000 | $398,000 | 0.17% |
| MENTA CAPITAL LLC | 39,562 | $243,000 | 0.09% |
| Campbell & CO Investment Adviser LLC | 12,990 | $88,000 | 0.09% |